Free shipping on all orders over $ 500

CBL0137

Cat. No. M9302

All AbMole products are for research use only, cannot be used for human consumption.

CBL0137 Structure
Synonym:

Curaxin 137; CBL-C137

Size Price Availability Quantity
1mg USD 45  USD45 In stock
2mg USD 65  USD65 In stock
5mg USD 135  USD135 In stock
10mg USD 220  USD220 In stock
25mg USD 435  USD435 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CBL0137 is a metabolically stable curaxin that activates p53 with an EC50 value of 0.37 µM and inhibits NF-κB with an EC50 of 0.47 µM. CBL0137 inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma. CBL0137 eradicates d rug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.

In mice, CBL0137 was effective against orthotopic gemcitabine resistant PANC-1 model and patient derived xenografts, in which CBL0137 anti-tumor effect related with overexpression of FACT. Moreover, the combination effects of CBL0137 and gemcitabine might be explained by the ability of CBL0137 to inhibit several transcriptional programs induced by gemcitabine, including NF-kappaB response and expression of ribonucleotide reductase.

Chemical Information
Molecular Weight 336.43
Formula C21H24N2O2
CAS Number 1197996-80-7
Solubility (25°C) DMSO 10 mM
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lock R, et al. Pediatr Blood Cancer. Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program.

[2] Burkhart C, et al. Oncotarget. Curaxin CBL0137 eradicates d rug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.

Related p53 Products
Pifithrin-α, p-Nitro, Cyclic

Pifithrin-α, p-Nitro, Cyclic (PFN-α) is cell-permeable and active-form p53 inhibitor. Pifithrin-α, p-Nitro, Cyclic behaves as a p53 posttranscriptional activity inhibitor. Pifithrin-α, p-Nitro, Cyclic do not prevent p53 phosphorylation on the S15 residue.

PK095 

PK095 is a p53 mutant stabilizer.

HLI373 

HLI373 is an efficacious Hdm2 inhibitor.

Cjoc42 

Cjoc42 is a compound capable of binding to gankyrin.

MDM2-IN-1 

MDM2-IN-1 is a synthetic MDM2-p53 interaction (MDM2) inhibitor and contains the trans (D-)configuration.

  Catalog
Abmole Inhibitor Catalog




Keywords: CBL0137, Curaxin 137; CBL-C137 supplier, p53, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.